BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23866307)

  • 21. A scintillator-based approach to monitor secondary neutron production during proton therapy.
    Clarke SD; Pryser E; Wieger BM; Pozzi SA; Haelg RA; Bashkirov VA; Schulte RW
    Med Phys; 2016 Nov; 43(11):5915. PubMed ID: 27806590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fast neutron absorbed dose distributions in the energy range 0.5-80 meV--a Monte Carlo study.
    Söderberg J; Carlsson GA
    Phys Med Biol; 2000 Oct; 45(10):2987-3007. PubMed ID: 11049184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of secondary neutron dose in proton therapy resulting from the use of a tungsten alloy MLC or a brass collimator system.
    Diffenderfer ES; Ainsley CG; Kirk ML; McDonough JE; Maughan RL
    Med Phys; 2011 Nov; 38(11):6248-56. PubMed ID: 22047390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are neutrons responsible for the dose discrepancies between Monte Carlo calculations and measurements in the build-up region for a high-energy photon beam?
    Ding GX; Duzenli C; Kalach NI
    Phys Med Biol; 2002 Sep; 47(17):3251-61. PubMed ID: 12361221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of neutron dose equivalent and its dependence on beam configuration for a passive scattering proton delivery system.
    Wang X; Sahoo N; Zhu RX; Zullo JR; Gillin MT
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1563-70. PubMed ID: 20097484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stray neutron radiation exposures from proton therapy: physics-based analytical models of neutron spectral fluence, kerma and absorbed dose.
    Shrestha S; Newhauser WD; Donahue WP; Pérez-Andújar A
    Phys Med Biol; 2022 Jun; 67(12):. PubMed ID: 35613603
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation and Mitigation of Secondary Dose Delivered to Electronic Systems in Proton Therapy.
    Wroe AJ
    Technol Cancer Res Treat; 2016 Feb; 15(1):3-11. PubMed ID: 25616623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary Neutron Dose From a Dynamic Collimation System During Intracranial Pencil Beam Scanning Proton Therapy: A Monte Carlo Investigation.
    Smith BR; Hyer DE; Hill PM; Culberson WS
    Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):241-250. PubMed ID: 30114462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of neutron dose equivalent from the Mevion S250 proton accelerator: measurements and calculations.
    Chen KL; Bloch CD; Hill PM; Klein EE
    Phys Med Biol; 2013 Dec; 58(24):8709-23. PubMed ID: 24301001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutron H*(10) inside a proton therapy facility: comparison between Monte Carlo simulations and WENDI-2 measurements.
    De Smet V; Stichelbaut F; Vanaudenhove T; Mathot G; De Lentdecker G; Dubus A; Pauly N; Gerardy I
    Radiat Prot Dosimetry; 2014 Oct; 161(1-4):417-21. PubMed ID: 24255173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary Neutron Doses to Pediatric Patients During Intracranial Proton Therapy: Monte Carlo Simulation of the Neutron Energy Spectrum and its Organ Doses.
    Matsumoto S; Koba Y; Kohno R; Lee C; Bolch WE; Kai M
    Health Phys; 2016 Apr; 110(4):380-6. PubMed ID: 26910030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of stray neutron doses inside the treatment room from a proton pencil beam scanning system.
    Mojżeszek N; Farah J; Kłodowska M; Ploc O; Stolarczyk L; Waligórski MP; Olko P
    Phys Med; 2017 Feb; 34():80-84. PubMed ID: 28131732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutron production from beam-modifying devices in a modern double scattering proton therapy beam delivery system.
    Pérez-Andújar A; Newhauser WD; Deluca PM
    Phys Med Biol; 2009 Feb; 54(4):993-1008. PubMed ID: 19147903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monte Carlo simulation of the neutron spectral fluence and dose equivalent for use in shielding a proton therapy vault.
    Zheng Y; Newhauser W; Klein E; Low D
    Phys Med Biol; 2009 Nov; 54(22):6943-57. PubMed ID: 19887713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary neutron and photon dose in proton therapy.
    Agosteo S; Birattari C; Caravaggio M; Silari M; Tosi G
    Radiother Oncol; 1998 Sep; 48(3):293-305. PubMed ID: 9925249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pitfalls of tungsten multileaf collimator in proton beam therapy.
    Moskvin V; Cheng CW; Das IJ
    Med Phys; 2011 Dec; 38(12):6395-406. PubMed ID: 22149823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutron scattered dose equivalent to a fetus from proton radiotherapy of the mother.
    Mesoloras G; Sandison GA; Stewart RD; Farr JB; Hsi WC
    Med Phys; 2006 Jul; 33(7):2479-90. PubMed ID: 16898451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monte Carlo simulations of neutron spectral fluence, radiation weighting factor and ambient dose equivalent for a passively scattered proton therapy unit.
    Zheng Y; Fontenot J; Taddei P; Mirkovic D; Newhauser W
    Phys Med Biol; 2008 Jan; 53(1):187-201. PubMed ID: 18182696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary neutron dosimetry for conformal FLASH proton therapy.
    Chen D; Motlagh SAO; Stappen FV; Labarbe R; Bell B; Kim M; Teo BK; Dong L; Zou W; Diffenderfer ES
    Med Phys; 2024 Apr; ():. PubMed ID: 38597815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secondary neutron dose during proton therapy using spot scanning.
    Schneider U; Agosteo S; Pedroni E; Besserer J
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):244-51. PubMed ID: 12007965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.